Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5064 | 1612 | 28.0 | 56% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
124 | 23152 | HEPATITIS B VIRUS//CHRONIC HEPATITIS B//HEPATITIS B |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | IGM ANTI HBC | Author keyword | 5 | 60% | 0% | 6 |
2 | ANTI HBC IGM | Author keyword | 3 | 60% | 0% | 3 |
3 | HBVDNA | Author keyword | 2 | 67% | 0% | 2 |
4 | PREDNISOLONE WITHDRAWAL | Author keyword | 2 | 67% | 0% | 2 |
5 | HBV ANTIGENS | Author keyword | 2 | 36% | 0% | 4 |
6 | HBCAG | Author keyword | 2 | 13% | 1% | 11 |
7 | ABBOTT HBV DNA ASSAY | Author keyword | 1 | 100% | 0% | 2 |
8 | CORTICOSTEROID WITHDRAWAL THERAPY | Author keyword | 1 | 100% | 0% | 2 |
9 | RIFN ALPHA | Author keyword | 1 | 40% | 0% | 2 |
10 | ADENINE ARABINOSIDE | Author keyword | 1 | 33% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IGM ANTI HBC | 5 | 60% | 0% | 6 | Search IGM+ANTI+HBC | Search IGM+ANTI+HBC |
2 | ANTI HBC IGM | 3 | 60% | 0% | 3 | Search ANTI+HBC+IGM | Search ANTI+HBC+IGM |
3 | HBVDNA | 2 | 67% | 0% | 2 | Search HBVDNA | Search HBVDNA |
4 | PREDNISOLONE WITHDRAWAL | 2 | 67% | 0% | 2 | Search PREDNISOLONE+WITHDRAWAL | Search PREDNISOLONE+WITHDRAWAL |
5 | HBV ANTIGENS | 2 | 36% | 0% | 4 | Search HBV+ANTIGENS | Search HBV+ANTIGENS |
6 | HBCAG | 2 | 13% | 1% | 11 | Search HBCAG | Search HBCAG |
7 | ABBOTT HBV DNA ASSAY | 1 | 100% | 0% | 2 | Search ABBOTT+HBV+DNA+ASSAY | Search ABBOTT+HBV+DNA+ASSAY |
8 | CORTICOSTEROID WITHDRAWAL THERAPY | 1 | 100% | 0% | 2 | Search CORTICOSTEROID+WITHDRAWAL+THERAPY | Search CORTICOSTEROID+WITHDRAWAL+THERAPY |
9 | RIFN ALPHA | 1 | 40% | 0% | 2 | Search RIFN+ALPHA | Search RIFN+ALPHA |
10 | ADENINE ARABINOSIDE | 1 | 33% | 0% | 2 | Search ADENINE+ARABINOSIDE | Search ADENINE+ARABINOSIDE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PREDNISONE WITHDRAWAL | 12 | 34% | 2% | 29 |
2 | LYMPHOBLASTOID INTERFERON | 6 | 16% | 2% | 31 |
3 | ANTI HBC IGM | 6 | 100% | 0% | 4 |
4 | SHORT TERM PREDNISOLONE | 6 | 100% | 0% | 4 |
5 | ADENINE ARABINOSIDE 5 MONOPHOSPHATE | 5 | 50% | 0% | 7 |
6 | SPOT HYBRIDIZATION | 5 | 50% | 0% | 7 |
7 | ADENINE ARABINOSIDE | 4 | 21% | 1% | 16 |
8 | HBCAG | 3 | 29% | 1% | 10 |
9 | HBC IGM | 3 | 60% | 0% | 3 |
10 | ANTI HBE | 3 | 18% | 1% | 14 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
INTERFERON IN THE MANAGEMENT OF CHRONIC HEPATITIS-B | 1993 | 60 | 84 | 48% |
Nuclear localization of hepatitis B core antigen and its relations to liver injury, hepatocyte proliferation, and viral load | 2003 | 14 | 15 | 67% |
IMMUNOPATHOLOGY OF CHRONIC VIRAL-HEPATITIS | 1991 | 20 | 100 | 69% |
SPONTANEOUS REACTIVATION OF CHRONIC HEPATITIS-B INFECTION LEADING TO FULMINANT HEPATIC-FAILURE - REPORT OF 2 CASES AND REVIEW OF THE LITERATURE | 1993 | 17 | 21 | 62% |
NATURAL-HISTORY OF CHRONIC HEPATITIS-B VIRUS-INFECTION - NEW LIGHT ON AN OLD STORY | 1993 | 50 | 41 | 24% |
TREATMENT AND PREVENTION OF CHRONIC VIRAL-HEPATITIS | 1995 | 21 | 135 | 24% |
Advances in the treatment of chronic hepatitis B virus infection | 1998 | 8 | 53 | 30% |
THE INTERFERON SYSTEM IN ACUTE AND CHRONIC VIRAL-HEPATITIS | 1986 | 60 | 26 | 54% |
THE IMPORTANCE OF HEPATITIS-B VIRAL-DNA IN SERUM AND LIVER | 1986 | 24 | 7 | 100% |
CURRENT STATUS OF INTERFERON-ALPHA IN THE TREATMENT OF CHRONIC HEPATITIS-B | 1992 | 6 | 19 | 68% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CATTEDRA CLIN MALATTIE INFETT | 1 | 50% | 0.1% | 1 |
2 | MED DENT LIVER UNIT | 1 | 50% | 0.1% | 1 |
3 | ST IVAN RILSKY UNIV HOSP | 1 | 50% | 0.1% | 1 |
4 | UNIT LIVER DIS | 1 | 29% | 0.1% | 2 |
5 | C PI LIVER UNIT | 0 | 33% | 0.1% | 1 |
6 | DDS S YODOGAWA KU | 0 | 33% | 0.1% | 1 |
7 | DEPARMENT INFECT DIS | 0 | 33% | 0.1% | 1 |
8 | GASTROINTESTINAL ENDOSCOPY ULTRASONOG | 0 | 33% | 0.1% | 1 |
9 | NUCLE ACID DIAGNOST | 0 | 33% | 0.1% | 1 |
10 | SCRIPPS IMMUNOL REFERENCE | 0 | 25% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000149344 | HEPATITIS DELTA VIRUS//HEPATITIS D VIRUS//HDV RNA |
2 | 0.0000148270 | BIO NANOCAPSULE//RECOMBINANT HEPATITIS B SURFACE ANTIGEN//PRE S1 |
3 | 0.0000124962 | IMMUNOLOGICAL AGENTS//INT MED PROGRAMME//CLINICAL PREDICTIONS |
4 | 0.0000112397 | INTERNAL MED MOL BIOL 2//HEPADNAVIRUS//DUCK HEPATITIS B VIRUS |
5 | 0.0000111424 | CHRONIC HEPATITIS B//ENTECAVIR//LAMIVUDINE |
6 | 0.0000101106 | HEPATITIS B VIRUS//PRECORE//PRECORE MUTATION |
7 | 0.0000089537 | HEPATITIS B VIRUS ASSOCIATED GLOMERULONEPHRITIS//HBV ASSOCIATED NEPHROPATHY//HEPATITIS B SURFACE ANTIGENEMIA |
8 | 0.0000079733 | IGA ALPHA 1 ANTITRYPSIN COMPLEX//IGA ALPHA1 ANTITRYPSIN COMPLEX//LOW MOLECULAR WEIGHT IGM |
9 | 0.0000074921 | ANGIOTONIN//HOSP UNIV CASSIANO ANTONIO DE MORAIS//HYPERTENSIN |
10 | 0.0000071698 | HBX//HEPATITIS B VIRUS X PROTEIN//X PROTEIN |